Albemarle Corporation to Release
First-Quarter 2023 Earnings Results on Wednesday, May 3, 2023Fri, April 7, 2023 at 8:30 AM GMT+12·2 min readMark this date in your diary. Waiting to hear what ALB have to say about Liontown.CHARLOTTE, N.C., April 6, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announThe company will hold its conference call to discuss first-quarter 2023 results on Thursday, May 4, at 9:00 a.m. ET. This call will be webcast and can be accessed through Albemarle Corporation's website at ced today that it will release its first-quarter 2023 earnings after the NYSE closes on Wednesday, May 3, 2023.
http://investors.albemarle.com, via the webcast link below or by phone at the following numbers:
ADVERTISEMENTPARTICIPANT INFORMATION (Public):United States: 1 833.470.1428
United States (Local): 1.404.975.4839
All other locations: +1 404.662.2808
Participant Access code: 741195
Participants will need to enter the participant access code before being met by an operator.Webcast DetailsEvent Title: Q1 2023 Albemarle Corporation Earnings Conference Call
Event Date: May 4, 2023
Start Time: 09:00 AM (GMT-04:00) Eastern Time (US and Canada)
Attendee URL (Public):https://events.q4inc.com/attendee/554774659To avoid registration wait times, participants are encouraged to use the webcast link as the primary listening source. If a caller is anticipating asking a question, please dial in 15 minutes before the start of the call to be placed in the queue early.
An online replay of this call will be available on Albemarle Corporation's website (for 12 months) and by phone at the following numbers (for 7 days):
- Forums
- ASX - By Stock
- LTR
- Lithium Related Media Articles
Lithium Related Media Articles, page-15823
-
-
- There are more pages in this discussion • 7,654 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
98.0¢ |
Change
-0.020(2.00%) |
Mkt cap ! $2.418B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 98.0¢ | $9.189M | 9.199M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
57 | 361712 | 98.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.5¢ | 127733 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
54 | 354663 | 0.980 |
13 | 335783 | 0.975 |
25 | 392957 | 0.970 |
8 | 689472 | 0.965 |
6 | 48696 | 0.960 |
Price($) | Vol. | No. |
---|---|---|
0.985 | 153102 | 16 |
0.990 | 143558 | 15 |
0.995 | 197591 | 16 |
1.000 | 355026 | 17 |
1.005 | 81239 | 7 |
Last trade - 15.17pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online